论文部分内容阅读
目的 :对记忆力减退患者 6 6例进行茴拉西坦 (阿尼西坦 )、吡拉西坦随机单盲阳性药物对照治疗并对疗效进行观察。方法 :治疗组 36例 ,每次服阿尼西坦 2 0 0mg ;对照组 30例 ,每次服吡拉西坦 40 0mg ;均为tid ,共 8周。 结果 :治疗组与对照组两组间治疗结束后记忆商 (MQ)比较有显著差异 ;治疗组自身治疗前后记忆商比较有显著差异 ;治疗后有效率治疗组高于对照组。结论 :阿尼西坦的疗效优于同类药物吡拉西坦 ,并且安全 ,不良反应小 ,适于临床应用。
Objective: Sixty-six patients with memory loss were treated with aniracetam (aniracetam) and piracetam random single-blind positive drug and the curative effect was observed. Methods: The treatment group of 36 cases, each serving aniracetam 200 mg; control group of 30 patients, each serving 40 mg of piracetam; are tid, a total of 8 weeks. Results: There was a significant difference in the memory quotient (MQ) between the treatment group and the control group after treatment; the treatment group had significant difference in the memory before and after treatment; and the effective rate in the treatment group was higher than that in the control group. Conclusion: The efficacy of aniracetam is superior to that of the same drug piracetam, and its safety and adverse reactions are small and suitable for clinical application.